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Objective: The purpose of the BalanceWise-hemodialysis study is to determine the efﬁ  cacy 
of a dietary intervention to reduce dietary sodium intake in patients receiving maintenance, 
in-center hemodialysis (HD). Personal digital assistant (PDA)-based dietary self-monitoring is 
paired with behavioral counseling. The purpose of this report is to present a case study of one 
participant’s progression through the intervention.
Methods: The PDA was individually programmed with the nutritional requirements of the 
participant. With 25 minutes of personalized instruction, the participant was able to enter his 
meals into the PDA using BalanceLog® software. Nutritional counseling was provided based 
on dietary sodium intake reports generated by BalanceLog®.
Results: At initiation of the study the participant required 4 HD treatments per week. The 
participant entered 342 meals over 16 weeks (3 meals per day). BalanceLog® revealed that 
the participant consumed restaurant/fast food on a regular basis, and consumed signiﬁ  cant 
amounts of corned beef as well as canned foods high in sodium. The study dietitian worked 
with the participant and his wife to identify food alternatives lower in sodium. Baseline sodium 
consumption was 4,692 mg, and decreased at a rate of 192 mg/week on average. After 11 weeks 
of intervention, interdialytic weight gains were reduced sufﬁ  ciently to permit the participant 
to reduce HD treatments from 4 to 3 per week. Because of a low serum albumin at baseline 
(2.9 g/dL) the study dietitian encouraged the participant to increase his intake of high quality 
protein. Serum albumin level at 16 weeks was unchanged (2.9 g/dL). Because of intense pruritis 
and a high baseline serum phosphorus (6.5 mg/dL) BalanceLog® electronic logs were reviewed 
to identify sources of dietary phosphorus and counsel the participant regarding food alternatives. 
At 16 weeks the participant’s serum phosphorus fell to 5.5 mg/dL.
Conclusions: Self-monitoring rates were excellent. In a HD patient who was willing to self-
monitor his dietary intake, BalanceLog® allowed the dietitian to target problematic foods and 
provide counseling that appeared to be effective in reducing sodium intake, reducing interdia-
lytic weight gain, and alleviating hyperphosphatemia and hyperkalemia. Additional research 
is needed to evaluate the efﬁ  cacy of the intervention.
Keywords: hemodialysis, self care, computers, handheld, personal digital assistant, randomized 
clinical trial, behavioral research, adherence
Introduction
In advanced kidney failure, the only available treatment options are home or in-center 
hemodialysis (HD), home peritoneal dialysis, or kidney transplant. More than 93% of 
individuals with end-stage renal disease (ESRD) begin treatment with HD, and almost 
all patients (99.6%) on HD receive in-center treatment (USRDS 2007). In-center 
HD treatment consists of thrice weekly visits to a local dialysis unit, during which 
patients are dialyzed to remove toxins, maintain ﬂ  uid balance, and normalize blood 
electrolytes. While kidney transplant yields the best outcomes in terms of morbidity, Patient Preferences and Adherence 2008:2 178
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mortality, health care cost, and quality of life, some HD 
patients are not eligible for transplant due to the underlying 
disease state or the presence of other comorbid conditions. 
These individuals must remain on dialysis for the rest of their 
lives. For those who are eligible for a transplant, unless a 
living donor is available the waiting time for a kidney can be 
many years. Therefore, maintaining health while on HD is a 
key management goal. Remaining healthy is a challenge, as 
HD cannot entirely replace kidney function, and in-center HD 
treatments are associated with a variety of problems, in part 
due to the intermittent nature of this form of dialysis.
To minimize the problems associated with intermittent 
dialysis, in-center HD patients need to follow a complicated 
and fairly restrictive dietary regimen. Hyperphosphatemia 
develops in patients with ESRD because phosphorus is not 
adequately removed by dialysis and must be controlled 
through oral intake of phosphorus binders and/or reduced 
dietary intake of phosphates. HD patients also must limit 
dietary consumption of potassium by limiting their intake of 
fresh fruits and vegetables, to prevent hyperkalemia. Protein-
energy malnutrition is common among HD patients (Rocco 
et al 2002), who must be vigilant to consume enough calories 
and high quality protein.
Sodium and ﬂ  uid control are perhaps the most important 
components of the HD diet. Excessive intake of sodium that 
is not excreted by failed kidneys results in intense thirst and, 
excessive ﬂ  uid intake. Extracellular volume expansion, which 
is controlled primarily through dietary intake of sodium, is 
the main pathophysiologic determinant of hypertension in 
HD patients (D’Amico and Locatelli 2002). Hypertension 
occurs in an estimated 72%–90% of HD patients (Salem 
1995; Rocco et al 2001; Agarwal 2000). An increase in pulse 
pressure, due to an increase in systolic blood pressure (BP), 
is an important predictor of survival in HD (Klassen et al 
2002). Recent small studies suggest that salt restriction and 
strict volume control can reduce interdialytic weight gain 
(IDWG) (Rigby-Matthews et al 1999; Ozkahya et al 2002) 
and, in turn, improve patient outcomes (Ozkahya et al 2002; 
Saran et al 2003).
The National Kidney Foundation recently released clinical 
practice recommendations for HD adequacy (NKF 2006). These 
guidelines highlight the importance of moderate dietary sodium 
restrictions (2–2.4 g/day) for controlling ﬂ  uid volume and BP, 
and ultimately reducing cardiovascular disease. These guidelines 
recommend that weight gain between dialysis treatments should 
not exceed 1 kg during the week and 1.5 to 2 kg during the week-
end. Adhering to such a complicated dietary regimen is likely to 
be difﬁ  cult for even the most motivated HD patient.
New dietary self-monitoring technologies may be useful for 
helping HD patients make good dietary decisions. The purpose 
of the BalanceWise-HD study was to pilot test a dietary inter-
vention to reduce sodium intake in in-center HD patients. The 
intervention involves behavioral counseling based on social 
cognitive theory (SCT), paired with personal digital assistant 
(PDA)-based dietary self-monitoring with BalanceLog® soft-
ware. In this case report we describe the implementation of the 
intervention in a study participant who experienced a reduction 
in IDWGs over the course of the study.
Case history
Participant (ppt) #03 is an African American male who began 
in-center HD in July of 2006 when he was 57 years old. His 
nephrotic syndrome and chronic kidney disease were due to 
biopsy-proven amyloidosis and focal segmental glomerulo-
sclerosis. He presented to the emergency department com-
plaining of general malaise and poor oral intake. His creatinine 
was 9.8 mg/dl. The acute component of his kidney failure was 
believed to be multifactorial from partial obstruction as well as 
prerenal, with perhaps some degree of acute tubular necrosis. 
While in the emergency department, ppt #03 was hydrated and 
a Foley catheter was placed. Despite these interventions his 
creatinine levels did not improve and HD was initiated in the 
inpatient setting via a temporary catheter. He was transferred 
subsequently to a skilled nursing facility and thrice weekly 
HD continued on an outpatient basis.
Ppt #03 was discharged home in November of 2006. 
Although his appetite was poor at the time of his discharge, 
it gradually improved over the subsequent 3 months. As his 
appetite increased, serum potassium and phosphorus levels 
increased. Hyperphosphatemia became a signiﬁ  cant problem, 
resulting in intense pruritis, and phosphate binders were added 
to his regimen. Although his serum albumin was low, a request 
for interdialytic parenteral nutrition was denied by his insur-
ance carrier. He was advised to drink protein powder supple-
ments but refused to do so. His increasing IDWGs necessitated 
the intensiﬁ  cation of his dialysis treatment regimen from 3 to 
4 days/week. Despite intensive dietary counseling as well as 
interest and willingness on the part of the ppt to learn more 
about the HD diet, laboratory data and IDWGs suggested non-
compliance to a difﬁ  cult and complicated dietary regimen.
Methods
In January 2007, ppt #03 enrolled in the 16-week Balance-
Wise Study. The BalanceWise-HD study is a randomized 
clinical trial to pilot test a dietary intervention to reduce 
dietary sodium intake. Hemodialysis patients are approached Patient Preferences and Adherence 2008:2 179
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by a dialysis center staff person to solicit their interest in 
the study. Those signing a Health Insurance Portability and 
Accountability Act (HIPAA) release are approached by a 
study staff person who obtains a signed informed consent. 
Participants are randomized to either intervention or to an 
attention control group.
The intervention involves dietary counseling based 
on SCT (Bandura 1986, 1997). Table 1 presents a list of 
Table 1 Common problems experienced by hemodialysis patients and examples of SCT-based behavioral solutions to enhance self-efﬁ  cacy
Common problems Counseling approach
Knowledge deﬁ  cits, nonadherence to dietary restrictions. 
The HD diet is complex, requiring patients to be knowledgeable, 
and aware of their intake of several key nutrients.
The intervention fosters a sense of mastery in adopting the HD diet. 
PDA self-monitoring permits the patient to become self-aware of 
their dietary patterns. In collaboration with the dietician the patient sets 
short-term, achievable goals that permit them to experience success in 
adhering to their dietary regimen.
Lifestyle change. Giving up favorite foods and otherwise changing 
dietary patterns require signiﬁ  cant motivation and self-discipline.
SCT interventions acknowledge that lifestyle changes do not occur 
overnight. Using individual counseling, patient values and goals regarding 
treatment are clariﬁ  ed, and behavior changes required to meet those goals 
are deﬁ  ned with the patient. “Stepped”, achievable goals are negotiated 
with the patient, allowing the patient to develop a sense that they are able 
to succeed in adhering to their diet (mastery). Verbal persuasion is 
used to reinforce to the patient that they are capable of making dietary 
changes. Stimulus control methods are use to help patients avoid cues to 
unhealthy food choices (eg, avoiding the chips and soda aisle when shopping) 
or change their response to cues by building healthier habits (eg, eating 
unsalted pretzels instead of potato chips). Involving the patient’s social 
support system is employed to encourage sustained healthy food choices.
Disruption of meals by dialysis. Our preliminary data and our clinical 
observations support the notion that dialysis treatments disrupt normal 
meals (either because of the timing of dialysis, or because patients feel 
“washed-out” after dialysis and do not feel like cooking or eating).
The dietician works with the patient to problem solve around meal 
disruptions. Example solutions could be drinking a can of Boost when 
the patient does not feel like eating, packing a meal the night before to 
take to the dialysis center, preparing meals in advance, cooking in volume 
and freezing single serving size meals.
Intra- and post-dialytic symptoms. Intradialytic hypotension and 
post-dialysis symptoms are associated with the rapid removal of ﬂ  uid 
during dialysis and are particularly problematic in patients with large 
interdialytic weight gains. During dialysis patients may experience malaise, 
muscle cramping, nausea, diarrhea, diaphoresis, chest pain, and visual 
changes. After dialysis, those who have experienced the removal of large 
amounts of ﬂ  uid are likely to feel extreme fatigue.
The dietitian works with the patient to identify the physiologic 
symptoms associated with high interdialytic weight gains, and recognize 
improvements that occur as a result of successes in reducing dietary 
sodium intake.
Anorexia, change in sense of taste. As a result of these changes, 
many HD patients do not eat properly.
Similar to giving-up favorite foods, eating a sufﬁ  cient amount of food 
may be a challenge to HD patients; motivation and self-discipline are 
required. As described in the “lifestyle” section above, verbal persuasion, 
mastery performance, stimulus control, and use of social support 
systems will be useful in assisting patients in making healthy food 
choices. Problem solving methods are used to identify and maximize 
incorporation of food preferences into the daily diet.
Dietary intolerances, diarrhea The dietician will work with the patients to problem solve around 
dietary intolerances, eg, suggesting alternative foods, gradual increases in 
serving sizes, etc.
Limited economic resources. Patients may have difﬁ  culty with the 
cost of healthy food choices.
The dietician will problem solve with the patient to identify 
inexpensive food choices, and will refer to the social worker as neces-
sary to obtain assistance whenever possible.
Periodic illness and hospitalization. Progress toward achieving a 
healthier diet may be interrupted by illness, hospitalization, or dietary 
lapses.
Patients will be counseled with regard to how they can deal with 
lapses and relapses. They will be told that lapses and relapses are 
common, and that they should not be discouraged by these. When lapses 
occur they are counseled to reformulate goals, as appropriate, to get 
back “on-track” toward achieving a healthier diet.Patient Preferences and Adherence 2008:2 180
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common diet-related problems experienced by HD patients 
and examples of SCT-based behavioral solutions used 
in the study to enhance adherence to the dialysis dietary 
regimen. Intervention participants also receive a PDA with 
BalanceLog® software. BalanceLog® allows participants to 
evaluate the content of various foods, track dietary intake, 
and evaluate the percent of dietary targets achieved by meal 
and by day. A description of BalanceLog® software when 
used within the context of a behavioral self-management 
intervention appears elsewhere (Sevick et al 2008).
Intervention participants are exposed to a 16-week inter-
vention with contacts performed during regularly scheduled 
inpatient dialysis treatments. The study dietitian reviews 
PDA electronic dietary records and provides counseling. 
Intervention contacts occur twice a week during weeks 1–6, 
weekly during weeks 7–12, and every other week for weeks 
13–16. (The gradual reduction in frequency of contacts is 
intended to assist the participant in independently maintain-
ing the newly acquired self-management behaviors after the 
intervention period has ended). Ppt #03 was one of the ﬁ  rst 
participants to enroll in this ongoing study, which anticipates 
a ﬁ  nal recruitment of 25–30 participants.
At the time of enrollment, ppt #03 was receiving 4 dialysis 
treatments per week to address his high IDWGs. His serum 
laboratory values on enrollment are shown in Table 2.
Ppt #03 was randomized to the intervention and provided 
with a PDA with BalanceLog® software. BalanceLog® was 
used to log dietary intake and provide graphical feedback to 
the ppt on the percent of target nutrients (sodium, protein, 
calories) that he consumed by meal and by day. The ppt 
also was shown how to track ﬂ  uid intake in the program. 
BalanceLog® was individually programmed for the nutri-
tional requirements of ppt #03 (Table 3).
Ppt #03 also was prescribed the upper limits of 2,000 mg/
day of potassium, and 1,000 mg/day of phosphorus. Although 
the software does not contain information on the potassium or 
phosphorus content of the foods in the BalanceLog® database, 
when monthly labs revealed hyperphosphatemia or hyper-
kalemia the electronic log was reviewed by the dietitian to 
identify high potassium and high phosphorus foods. The ppt 
then was counseled regarding approaches for staying within 
the prescribed targets.
Ppt #03 received individualized instruction on entering 
foods into BalanceLog®. He was shown a PowerPoint slide 
demonstration of how to enter foods into the program, and 
followed along on his individually programmed PDA. The 
ppt was instructed to record his meals and snacks as soon as 
possible after eating so that recalling the food several hours 
later would not be an issue, a phenomenon that is common 
among individuals who self-monitor dietary intake (Burke 
et al 2006, 2008).
Instruction of ppt #03 required approximately 25 minutes 
of staff time. After initial training, the study dietitian met with 
ppt #03 according to the schedule described above. Using the 
dietary logs, routinely schedule laboratory test data (serum 
albumin, potassium, phosphorus), and information on IDWG, 
the study dietitian worked with ppt #03 to identify potential 
problems, assist him in setting realistic goals for dietary 
change, evaluate goal achievement, and provide the feedback 
and encouragement important to developing his sense of 
mastery over the dietary regimen. Whenever possible, the 
participant’s wife was included in counseling sessions.
Results
After a single instruction session, ppt #03 entered meals every 
day for the duration of the 16-week intervention (including 
7 days during which he was hospitalized). The participant 
entered 342 meals over 16 weeks (3 meals per day). 
Although the focus of the intervention was the reduction 
of dietary sodium intake, ppt #03 was highly motivated to 
reduce his dialysis treatments from a 4 day/week regimen 
to 3 days/week. The study dietitian noted on his dietary logs 
that ppt #03 was eating frequently at restaurants, including 
fast food establishments. He also was consuming a signiﬁ  -
cant amount of corned beef as well as canned foods high in 
sodium. The dietitian worked with the ppt and his wife to 
identify food alternatives lower in sodium. In particular the 
dietitian advised them to minimize their consumption of 
restaurant/fast food. When consuming protein, they were 
advised to eat fresh, unprocessed meats. They also were 
advised to minimize the consumption of canned vegetables. 
Table 2 Serum laboratory values of participant 03 on enrollment
Serum laboratory 
test
Value Normal range
Albumin 2.9 g/dL 3.8
Potassium 6.0 Eq/L 3.5–5.5
Phosphorus 6.5 mg/dL 3.5–5.5
Table 3 Nutritional requirements of participant 03 programmed 
into PDA
Target calories 2,175 kcal
Target protein 130 g/day
Sodium (upper limit) 2,000 mg/daPatient Preferences and Adherence 2008:2 181
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When this was not possible, they were advised to rinse the 
vegetables to eliminate as much sodium as possible.
Figure 1 shows the daily sodium consumption for ppt #03 
over the 16-week study period, uploaded from his PDA elec-
tronic record, with a super-imposed linear regression line. 
Based on the ﬁ  tted regression line, the estimated baseline daily 
sodium consumption was 4,692 mg and decreased at a rate of 
192 mg per week on average. By the end of the study period, 
his daily sodium consumption decreased by an estimated 
3,077 mg from the baseline level, with a ﬁ  nal average below 
the ceiling recommended by the National Kidney Foundation. 
Furthermore, the extremely high values (6,000 mg sodium) 
did not occur after the ﬁ  rst few weeks of the study.
Because of intense pruritis and a high baseline serum 
phosphorus level (6.5mg/dL) the study dietitian reviewed the 
BalanceLog® electronic logs to identify sources of dietary 
phosphorus. The study dietitian found that the patient was 
consuming large quantities of chili with cheese and beans 
almost daily and was not taking phosphorus binders with 
each meal. By 16 weeks the ppt’s phosphorus had fallen to 
5.5 mg/dL. As noted above, the ppt was advised to maintain 
adequate dietary intake of protein by consuming high quality 
proteins, and by trying to eat the protein component of his 
meal ﬁ  rst. Serum albumin at 16 weeks was unchanged.
The ppt had a serum K+ lab value of 6.0 mEq/L at the 
initiation of the study. The study dietitian reviewed with the 
ppt instructional materials on limiting dietary potassium. She 
also provided a USDA list of foods and their respective potas-
sium content to him and his wife. After 1 month of dietary 
counseling his K+ dropped to 4.4 mEq/L and continued to 
remain in the normal range until the conclusion of the study, 
when his K+ was 5.1 mEq/L.
We also evaluated the impact of the intervention on 
IDWG. IDWGs are a function of the number of days that 
have elapsed between dialysis treatments. For example, 
in those participants who dialyze on the usual 3 day/week 
schedule, the interval between dialysis treatments will vary 
from 2–3 days. For those who dialyze on a 4 day/week sched-
ule, the interval between dialysis treatments will vary from 
1–3 days. To account for variation in IDWG by treatment 
interval, we calculated the average daily IDWG (IDWGA) for 
each dialysis treatment, as the total IDWG for each treatment 
observation divided by the number of days that had elapsed 
since the last HD treatment.
Figure 2 shows the IDWGAs for ppt #03 over the 16-week 
intervention with a superimposed linear regression line. Based 
on the ﬁ  tted regression line, the estimated IDWGA for ppt #03 
was 1.49.kg at baseline, and decreased at a rate of 0.012 kg 
per week on average. By the end of this 16 week study, his 
IDWGA had decreased from baseline by an estimated 0.19 kg, 
or his IDWG decreased by 0.38 kg between two weekday 
dialysis sessions (eg, Monday and Wednesday). After 
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11 weeks of intervention, IDWGs were reduced sufﬁ  ciently 
to permit ppt #03 to decrease his dialysis regimen from 4 to 
3 days/week.
Discussion
Dietary change is widely recognized to be difficult to 
initiate and sustain in healthy populations (Burke et al 1997; 
Kumanyika et al 2000; Rothman 2000; Rothman et al 2004). 
Dietary change is likely to be even more difﬁ  cult for patients 
on intermittent in-center HD because of the complexity of 
the dialysis diet and the numerous other nondietary demands 
of the treatment regimen. Sodium intake is particularly 
difﬁ  cult to control because many foods are naturally high 
in sodium, and most prepared/prepackaged foods have 
signiﬁ  cant amounts of sodium added to enhance taste and 
prolong shelf-life. Perhaps because the dietary regimen is so 
complex, most of the research surrounding management of 
ﬂ  uid volume has focused on restricting ﬂ  uid intake, or using 
medications and manipulating dialysis treatments. However, 
we believe that with advent of new information technolo-
gies, healthcare professionals now are positioned to help HD 
patients make better dietary decisions.
Because HD dietary recommendations often conﬂ  ict, use 
of dietary self-monitoring software such as BalanceLog® 
may be particularly useful for this patient population. 
For example, HD patients often experience a loss of appetite. 
Counseling them to reduce their dietary sodium intake could 
result in the elimination of many of their favorite foods. 
If acceptable alternatives are not identiﬁ  ed, the patient 
may be placed at increased risk of malnutrition. Similarly, 
counseling HD patients who have a low serum albumin to 
consume more protein may result in hyperphosphatemia. 
Switching from canned to frozen or fresh foods (especially 
vegetables) may result in hyperkalemia. Use of programs 
such as BalanceLog® allows the dietitian to target dietary 
problems as they arise, and allows the patient to consider 
the real time dietary consequences of adherence to dietary 
recommendations. Given his high rate of self-monitoring, 
the use of BalanceLog® did not appear to be burdensome to 
ppt #03. This case study suggests that the intervention, which 
is currently being tested in a small randomized study, may be 
effective for reducing dietary sodium intake and IDWGA.
However, caution must be used in drawing firm 
conclusions from the data presented for several reasons. First, 
the case was not selected randomly. Ppt #03 was selected 
for this case study because of his high baseline IDWGs, his 
high level of adherence to PDA self-monitoring, and the 
possibility that the intervention resulted in dietary changes 
that could have led to the improvements described. Ppt #03 
may not be typical of the average HD patient.
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Second, it is not clear to what extent reductions in 
dietary sodium intake and IDWG were the result of PDA 
self-monitoring versus the additional attention the partici-
pant received from the dietitian. As the study progresses, 
we plan to discount the potential competing hypothesis that 
improvements seen could have been due to additional atten-
tion, by virtue of our design which employs randomization 
and an attention control group.
Third, we cannot be certain of whether the normalization 
of serum phosphorus was due to reduced dietary phosphorus 
or better compliance with phosphate binders, because the study 
dietitian counseled ppt #03 about both, and because adherence 
to phosphate binders was not measured. However, we do know 
that dietary recalls performed prior to the intervention had 
been unsuccessful in revealing the source of the participant’s 
hyperphosphatemia. A food log that is completed in real time 
may allow clinicians to identify and address dietary problems 
more accurately and efﬁ  ciently than is possible with dietary 
recalls which are dependent on the memory of the patient. It 
is also possible that better phosphate management was due to 
increased dialysis dose or a change of dialyzer membrane, data 
that were not collected in this study.
Fourth, changes in IDWG can be inﬂ  uenced by a number 
of factors that were not measured in this small pilot study. 
For example, patients with very high IDWGs require removal 
of a large volume of ﬂ  uid (referred to as ultraﬁ  ltration in the 
dialysis literature). High levels of ultraﬁ  ltration are associ-
ated with hypotension which may require ﬂ  uid replacement 
during dialysis. This ﬂ  uid replacement may, in turn, result in 
net inadequate ﬂ  uid removal. For many patients, particularly 
for those with high IDWGs, ﬂ  uid removal is accompanied by 
intradialytic symptoms such as cramping, nausea, vomiting, 
and diarrhea. To ease the discomfort and enhance tolerability 
of ﬂ  uid removal, some physicians will prescribe sodium mod-
eling. In sodium modeling, a dialysate solution with a higher 
concentration of sodium is used initially during treatment, 
with sodium concentration decreased over the course of 
dialysis. Although it alleviates intradialytic symptoms, 
sodium modeling increases the patient’s serum sodium and, 
thus, may increase postdialytic thirst and subsequent IDWG. 
Several other factors may impact IDWG, such as changes 
in cardiovascular conditions, residual renal function, Kt/V 
(dialysis dose), dry weight (eg, weight gain or loss in body fat 
or lean body mass), glycemic control (in those with diabetes), 
inﬂ  ammation, and general nutritional status (Lopez-Gomez 
et al 2005).
Finally, PDA records provide a convenient source of 
information on possible changes in dietary patterns over 
time. However, the use of dietary records obtained from the 
PDA as a measure of dietary change potentially confounds 
independent and dependent variables. In future reports, we 
will be able to present the results of independent measures 
of dietary intake, including sodium consumption from 
dietary recalls obtained with unscheduled telephone calls 
to the participant’s home over a 2-week period, including 
one dialysis weekday, one nondialysis weekday, and one 
nondialysis weekend day.
Conclusion
The dietary self-monitoring intervention, which aims to 
reduce ﬂ  uid volume overload by reducing dietary sodium 
intake appears to be feasible, and may be effective in reducing 
sodium intake, increasing dietary self-efﬁ  cacy, and reducing 
IDWG.
Disclosure
This study was supported through a grant from the Paul 
Teschan Research Foundation. The authors report no con-
ﬂ  icts of interest in this work.
References
Agarwal R. 2000. Strategies and feasibility of hypertension control in a 
prevalent hemodialysis cohort. Clin Nephrol, 53:344–53.
Bandura A. 1986. Social Foundations of Thought and Action: A Social 
Cognitive Theory. Englewood Cliffs, NJ, Prentice Hall.
Bandura A. 1997. Self-Efﬁ  cacy: The Exercise of Control. New York: 
Freeman and Co.
Burke LE, Dunbar-Jacob J, Hill M, et al. 1997. Compliance to cardiovascular 
risk reduction strategies: Review of the research. Ann Behav Med, 
19:239–63.
Burke LE, Sereika SM, Choo J, et al. 2008. Ancillary study to the PREFER 
trial: A descriptive study of participants’ patterns of self-monitoring: 
Rationale, design and preliminary experiences. Contemp Clin Trials, 
21:23–33.
Burke LE, Sereika SM, Music E, et al. 2008. Using instrumented paper 
diaries to document self monitoring patterns in weight loss. Contemp 
Clin Trials, 29:182–93.
D’Amico M, Locatelli F. 2002. Hypertension in dialysis: pathophysiology 
and treatment. J Nephrol, 15:438–45.
Klassen PS, Lowrie EG, Reddan DN, et al. 2002. Association between 
pulse pressure and mortality in patients undergoing maintenance 
hemodialysis. JAMA, 287:1548–55.
Kumanyika SK, Van Horn L, Bowen D. 2000. Maintenance of dietary 
behavior change. Health Psychol, 19(1 Suppl):42–56.
Lopez-Gomez JM, Villaverde M, Jofre R, et al. 2005. Interdialytic 
weight gain as a marker of blood pressure, nutrition, and survival in 
hemodialysis patients. Kidney Int Suppl, 67:S63–S68.
[NKF] National Kidney Foundation. 2006. Clinical practice guidelines for 
hemodialysis adequacy. Am J Kidney Dis, 48:S13–97.
Ozkahya M, Toz H, Ozerkan F, et al. 2002. Impact of volume control on left 
ventricular hypertrophy in dialysis patients. J Nephrol, 15:655–60.
Rigby-Mathews A, Scribner BH, Ahmad S. 1999. Control of interdialytic 
weight gain (IDWG) without water restriction in hemodialysis. J Am Soc 
Nephrol, 10:A1348.Patient Preferences and Adherence 2008:2 184
Sevick et al
Rocco MV, Paranandi L, Burrowes JD, et al. 2002. Nutritional status in 
the HEMO Study cohort at baseline. Hemodialysis. Am J Kidney Dis, 
38:245–56.
Rocco MV, Yan G, Heyka RJ, et al. 2001. Risk factors for hypertension in 
chronic hemodialysis patients: baseline data from the HEMO study. 
Am J Nephrol, 21:280–8.
Rothman AJ, Baldwin AS, Hertel AW. 2004. Self-regulation and behavior 
change: Disentangling behavioral initiation and behavioral maintenance. 
In: Vohs K, Baumeister R (eds). The Handbook of Self-Regulation 
Research. New York: Guilford Press, pp. 130–48.
Rothman AJ. 2000. Toward a theory-based analysis of behavioral mainte-
nance. Health Psychol, 19:64–9.
Salem MM. 1995. Hypertension in the hemodialysis population: a survey 
of 649 patients Am J Kidney Dis, 26:461–8.
Saran R, Bragg-Gresham JL, Rayner HC, et al. 2003. Nonadherence in 
hemodialysis: Associations with mortality, hospitalization, and practice 
patterns in the DOPPS. Kidney Int, 64:254–62.
Sevick MA, Korytkowski M, Piraino B, et al. 2008. Design, feasibility, and 
acceptability of an intervention using personal digital assistant-based 
self-monitoring in managing type 2 diabetes. Contemp Clin Trials, 
29:396–409.
[USRDS] US Renal Data System. 2007. Annual Data Report: Atlas of 
End-Stage Renal Disease in the United States. Bethesda, MD: National 
Institutes of Health, National Institute of Diabetes and Digestive and 
Kidney Diseases.